Pharmather Holdings Ltd
CNSX:PHRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pharmather Holdings Ltd
CNSX:PHRM
|
CA |
Pharmather Holdings Ltd
PharmaTher Holdings Ltd. is a specialty psychedelic pharmaceutical company, which engages in the research, development and commercialization of ketamine and novel microneedle patches for delivering psychedelics to treat neuropsychiatric, neurodegenerative, and pain disorders. The company is headquartered in Toronto, British Columbia. The company went IPO on 2020-10-09. The firm is focused on the research, development and commercialization uses, formulations and delivery methods of psychedelics to treat mental illness, neurological and pain disorders. The firm's product pipeline targets the use of ketamine to treat Parkinson’s disease, depression, amyotrophic lateral sclerosis (Lou Gehrig’s disease) and pain. The firm is also focused on developing a microneedle patch to deliver ketamine and other psychedelics, such as psilocybin, N, N-Dimethyltryptamine (DMT), Lysergic acid diethylamide (LSD) and 3,4-Methylenedioxymethamphetamine (MDMA).
PharmaTher Holdings Ltd. is a specialty psychedelic pharmaceutical company, which engages in the research, development and commercialization of ketamine and novel microneedle patches for delivering psychedelics to treat neuropsychiatric, neurodegenerative, and pain disorders. The company is headquartered in Toronto, British Columbia. The company went IPO on 2020-10-09. The firm is focused on the research, development and commercialization uses, formulations and delivery methods of psychedelics to treat mental illness, neurological and pain disorders. The firm's product pipeline targets the use of ketamine to treat Parkinson’s disease, depression, amyotrophic lateral sclerosis (Lou Gehrig’s disease) and pain. The firm is also focused on developing a microneedle patch to deliver ketamine and other psychedelics, such as psilocybin, N, N-Dimethyltryptamine (DMT), Lysergic acid diethylamide (LSD) and 3,4-Methylenedioxymethamphetamine (MDMA).
